BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12587191)

  • 1. Inositol monophosphatase activity in brain and lymphocyte-derived cell lines of bipolar patients.
    Shaltiel G; Shamir A; Nemanov L; Yaroslavsky Y; Nemets B; Ebstein RP; Belmaker RH; Agam G
    World J Biol Psychiatry; 2001 Apr; 2(2):95-8. PubMed ID: 12587191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder.
    Shamir A; Elhadad N; Belmaker RH; Agam G
    Bipolar Disord; 2005 Feb; 7(1):42-8. PubMed ID: 15654931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder.
    Shimon H; Agam G; Belmaker RH; Hyde TM; Kleinman JE
    Am J Psychiatry; 1997 Aug; 154(8):1148-50. PubMed ID: 9247405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased inositol-monophosphatase activity by lithium treatment in bipolar patients.
    Kaya N; Resmi H; Ozerdem A; Guner G; Tunca Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):521-7. PubMed ID: 15093960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
    Atack JR; Broughton HB; Pollack SJ
    Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.
    Parthasarathy LK; Seelan RS; Wilson MA; Vadnal RE; Parthasarathy RN
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):55-60. PubMed ID: 12551726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scyllo-inositol in post-mortem brain of bipolar, unipolar and schizophrenic patients.
    Shapiro J; Belmaker RH; Biegon A; Seker A; Agam G
    J Neural Transm (Vienna); 2000; 107(5):603-7. PubMed ID: 11072754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol levels are decreased in postmortem brain of schizophrenic patients.
    Shimon H; Sobolev Y; Davidson M; Haroutunian V; Belmaker RH; Agam G
    Biol Psychiatry; 1998 Sep; 44(6):428-32. PubMed ID: 9777173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
    Vadnal R; Parthasarathy R
    Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low GSK-3 activity in frontal cortex of schizophrenic patients.
    Kozlovsky N; Belmaker RH; Agam G
    Schizophr Res; 2001 Oct; 52(1-2):101-5. PubMed ID: 11595396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of lithium on expression of genes for inositol biosynthetic enzymes in mouse hippocampus; a comparison with the yeast model.
    Shamir A; Shaltiel G; Greenberg ML; Belmaker RH; Agam G
    Brain Res Mol Brain Res; 2003 Jul; 115(2):104-10. PubMed ID: 12877981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human chromosomal localization of a gene for inositol monophosphatase by fluorescence in situ hybridization.
    Vadnal R; Heng HH; Parthasarathy L; Parthasarathy R
    Neuroreport; 1998 Mar; 9(4):683-5. PubMed ID: 9559938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence-based identification of inositol monophosphatase-like histidinol-phosphate phosphatases (HisN) in Corynebacterium glutamicum, Actinobacteria, and beyond.
    Kulis-Horn RK; Rückert C; Kalinowski J; Persicke M
    BMC Microbiol; 2017 Jul; 17(1):161. PubMed ID: 28720084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: molecular and behavioral aspects.
    Levi I; Eskira Y; Eisenstein M; Gilon C; Hoffman A; Tal-Gan Y; Fanous J; Bersudsky Y; Belmaker RH; Agam G; Almog O
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1806-15. PubMed ID: 23619164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid inositol monophosphatase: elevated activity in depression and neuroleptic-treated schizophrenia.
    Atack JR; Levine J; Belmaker RH
    Biol Psychiatry; 1998 Sep; 44(6):433-7. PubMed ID: 9777174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of inositol monophosphatase in human cerebrospinal fluid.
    Atack JR; Rapoport SI; Varley CL
    Brain Res; 1993 Jun; 613(2):305-8. PubMed ID: 8186981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain inositol monophosphatase identified as a galactose 1-phosphatase.
    Parthasarathy R; Parthasarathy L; Vadnal R
    Brain Res; 1997 Dec; 778(1):99-106. PubMed ID: 9462881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the lithium binding site in inositol monophosphatase, the putative target for lithium therapy, by magic-angle-spinning solid-state NMR.
    Haimovich A; Eliav U; Goldbourt A
    J Am Chem Soc; 2012 Mar; 134(12):5647-51. PubMed ID: 22384802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular antisense to inositol monophosphatase-1 reduces enzyme activity but does not affect Li-sensitive behavior.
    Shamir A; Shaltiel G; Agam G
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):103-6. PubMed ID: 11853098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bipolar disorder on lymphocyte inositol monophosphatase mRNA levels.
    Nemanov L; Ebstein RP; Belmaker RH; Osher Y; Agam G
    Int J Neuropsychopharmacol; 1999 Mar; 2(1):25-29. PubMed ID: 11281967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.